WO2006096998A1 - Agent servant a supprimer des tatouages - Google Patents

Agent servant a supprimer des tatouages Download PDF

Info

Publication number
WO2006096998A1
WO2006096998A1 PCT/CH2005/000156 CH2005000156W WO2006096998A1 WO 2006096998 A1 WO2006096998 A1 WO 2006096998A1 CH 2005000156 W CH2005000156 W CH 2005000156W WO 2006096998 A1 WO2006096998 A1 WO 2006096998A1
Authority
WO
WIPO (PCT)
Prior art keywords
composition according
aqueous solution
agent
encapsulated
juice
Prior art date
Application number
PCT/CH2005/000156
Other languages
German (de)
English (en)
Inventor
Remo Stoop
Original Assignee
Remo Stoop
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Remo Stoop filed Critical Remo Stoop
Priority to PCT/CH2005/000156 priority Critical patent/WO2006096998A1/fr
Publication of WO2006096998A1 publication Critical patent/WO2006096998A1/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A61Q1/145—Tattoo removal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/20—Halogens; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A61K8/553—Phospholipids, e.g. lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/02—Preparations for care of the skin for chemically bleaching or whitening the skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/20—Chemical, physico-chemical or functional or structural properties of the composition as a whole
    • A61K2800/21—Emulsions characterized by droplet sizes below 1 micron

Definitions

  • the present invention relates to a means for removing tattoos according to the preamble of claim 1.
  • the object of the invention is to eliminate the said and still further disadvantages of this prior art.
  • halide anions in particular chloride ions have been found to be particularly suitable.
  • Alkali cations are particularly suitable as counterions.
  • the aqueous solution has a pH below 7.0, preferably below 6.3. This value has proven to be particularly suitable in the process of encapsulating the aqueous solution in the phospholipid structures.
  • the pH of the aqueous solution is above 4.0, preferably above 5.0.
  • the solution is encapsulated in liposomes, i. in a single or multi-layer phospholipid double membrane which encloses the aqueous phase.
  • liposomes are advantageously high purity soy lecithins.
  • the agent may also be present in the form of a nanoemulsion.
  • the phospholipid structure is preferably based on phosphatidylcholine (PC).
  • PC phosphatidylcholine
  • phosphatidylethanolamine and / or lysophosphatidylcholine (LPC) may also be added.
  • the sodium chloride has been found.
  • the composition comprises a weak acid having an acid constant of 10 -2 mol / l ⁇ Ki ⁇ 10 "5 mol / l, a fruit acid, preferably citric acid, for example.
  • the agent contains juice of a citrus fruit, preferably pineapple juice.
  • Citrus fruits are those which belong to the genus citrus, in particular grapefruit, lemons, oranges, oranges, tangerines and limes.
  • the concentration of the halide anions in the aqueous solution is expediently below 20% by weight, preferably below 16.5% by weight.
  • the concentration of the halide anions in the aqueous solution is expediently more than 10% by weight, preferably more than 12.5% by weight.
  • the aqueous solution additionally contains kusnussmilk or coconut juice.
  • the aqueous solution and the coconut milk are conveniently mixed in the ratio of 3: 1 to 1: 1, preferably two parts of aqueous solution and one part of coconut milk.
  • the agent according to the invention may additionally contain starch, preferably in the form of potato juice.
  • the composition may also contain one or more additives, preferably preservatives, oxidants, whitening agents or buffers.
  • suitable whitening agents are tyrosinase inhibitors, scavengers for free radicals, hydroquinone, vitamin C and its derivatives, arbutin and glutathione.
  • the phospholipid structure advantageously comprises unsaturated phospholipids.
  • ingredients of the ginger may additionally be added to the encapsulated phospholipid structure, preferably in an amount of 1-10% by weight, based on 100% of the encapsulated phospholipid structure.
  • the ingredients of ginger have the beneficial effect of opening the main pores. This achieves an additional, improved effect of the agent, since active ingredients that are not encapsulated in the liposomes, but only surrounding exist, can thus penetrate into deeper skin layers in this way.
  • the proportion of the aqueous solution may be between 3 and 18% by weight, preferably between 7 and 14% by weight of the total composition.
  • the agent is placed on a tattooed skin area.
  • penetration of the agent into the skin is promoted by appropriate means, e.g. by massaging, so that the agent is transported by diffusion to the dye-bearing skin layer.
  • the agent can also be mechanically brought to the dye to be removed, which lies under the skin surface.
  • the pH of this solution was 6.0.
  • This mixture was encapsulated in liposomes (based on high purity soy lecithins) by known methods.
  • the tattoo removing agent contains the juice of a citrus fruit, with the juice of the pineapple fruit being the most effective. Furthermore, this agent advantageously also contains coconut milk.
  • the pineapple juice and the coconut milk are advantageously mixed in the ratio of two parts of pineapple juice and one part of coconut milk. The mixing ratio may vary within the limits of plus / minus ten percent.
  • This mixture is also common salt, preferably iodine-containing, attached. In the mixture of citrus juice and coconut milk, 100 to 200 grams, preferably 110 grams of the iodine-containing cooking salt are dissolved per liter of liquid.
  • the agent thus obtained was applied to a tattooed skin area and massaged until the agent was acted on the skin.
  • the active ingredients were transported by diffusion into the skin layer in which the dyes of the tattoo are embedded.
  • the pH of this solution was 6.0.
  • This mixture was encapsulated in liposomes (based on high purity soya lecithins) by known methods and the resulting product was mixed in a ratio of 20: 1 with ginger concentrate.
  • the agent thus obtained was applied to a tattooed skin area and massaged until the agent was absorbed into the skin.

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Dermatology (AREA)
  • Inorganic Chemistry (AREA)
  • Cosmetics (AREA)
  • Medicinal Preparation (AREA)

Abstract

L'invention concerne un agent servant à supprimer des tatouages, comprenant une solution aqueuse qui présente une teneur en anions halogénure et qui est encapsulée dans une structure phospholipidique.
PCT/CH2005/000156 2005-03-15 2005-03-15 Agent servant a supprimer des tatouages WO2006096998A1 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
PCT/CH2005/000156 WO2006096998A1 (fr) 2005-03-15 2005-03-15 Agent servant a supprimer des tatouages

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PCT/CH2005/000156 WO2006096998A1 (fr) 2005-03-15 2005-03-15 Agent servant a supprimer des tatouages

Publications (1)

Publication Number Publication Date
WO2006096998A1 true WO2006096998A1 (fr) 2006-09-21

Family

ID=35311923

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CH2005/000156 WO2006096998A1 (fr) 2005-03-15 2005-03-15 Agent servant a supprimer des tatouages

Country Status (1)

Country Link
WO (1) WO2006096998A1 (fr)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160175211A1 (en) * 2014-12-23 2016-06-23 Klaus Böde Method for the Removal of Tattoos and Skin Discolouration
CN111840230A (zh) * 2020-08-13 2020-10-30 蚌埠学院 生姜挥发油脂质体及其制备方法和其应用

Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR609177A (fr) * 1925-11-19 1926-08-10 Procédé et agent efficace pour la destruction des tatouages
WO1989012440A1 (fr) * 1988-06-22 1989-12-28 Johann Ribi Element et procede cosmetiques d'effacement de tatouages
WO1990012565A1 (fr) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Formulations aqueuses avec phospholipides
EP0930064A2 (fr) * 1997-12-20 1999-07-21 Merz & Co. GmbH & Co. Additif pour le bain sous la forme de comprimé effervescent à utiliser dans la balneothérapie, son procedé de préparation et son utilisation
WO2000076458A2 (fr) * 1999-06-10 2000-12-21 Coty B.V. Produit cosmetique contenant des enzymes
DE20209676U1 (de) * 2002-06-22 2002-09-26 Stubna Eduard Mittel zum Entfernen von Tätowierungen
US20050008685A1 (en) * 2003-07-07 2005-01-13 Mitchell Cheryl R. Oral rehydration compositions containing liposomes
WO2005027868A1 (fr) * 2003-09-24 2005-03-31 Remo Stoop Agent pour enlever des tatouages

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR609177A (fr) * 1925-11-19 1926-08-10 Procédé et agent efficace pour la destruction des tatouages
WO1989012440A1 (fr) * 1988-06-22 1989-12-28 Johann Ribi Element et procede cosmetiques d'effacement de tatouages
WO1990012565A1 (fr) * 1989-04-25 1990-11-01 Nattermann, A. & Cie. Gmbh Formulations aqueuses avec phospholipides
EP0930064A2 (fr) * 1997-12-20 1999-07-21 Merz & Co. GmbH & Co. Additif pour le bain sous la forme de comprimé effervescent à utiliser dans la balneothérapie, son procedé de préparation et son utilisation
WO2000076458A2 (fr) * 1999-06-10 2000-12-21 Coty B.V. Produit cosmetique contenant des enzymes
DE20209676U1 (de) * 2002-06-22 2002-09-26 Stubna Eduard Mittel zum Entfernen von Tätowierungen
US20050008685A1 (en) * 2003-07-07 2005-01-13 Mitchell Cheryl R. Oral rehydration compositions containing liposomes
WO2005027868A1 (fr) * 2003-09-24 2005-03-31 Remo Stoop Agent pour enlever des tatouages

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
OKU, NAOTO ET AL: "Differential effects of alkali metal chlorides on formation of giant liposomes by freezing and thawing and by dialysis", BIOCHEMISTRY , 22(4), 855-63 CODEN: BICHAW; ISSN: 0006-2960, 1983, XP009057593 *
RAPPOLT, MICHAEL ET AL: "L.alpha.-phase separation in phosphatidylcholine -water systems induced by alkali chlorides", BIOCHIMICA ET BIOPHYSICA ACTA, BIOMEMBRANES , 1372(2), 389-393 CODEN: BBBMBS; ISSN: 0005-2736, 1998, XP009057579 *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20160175211A1 (en) * 2014-12-23 2016-06-23 Klaus Böde Method for the Removal of Tattoos and Skin Discolouration
US10245219B2 (en) * 2014-12-23 2019-04-02 Klaus Böde Method for the removal of tattoos and skin discolouration
CN111840230A (zh) * 2020-08-13 2020-10-30 蚌埠学院 生姜挥发油脂质体及其制备方法和其应用

Similar Documents

Publication Publication Date Title
EP0217975A1 (fr) Mélange de sels pour le traitement du psoriasis et autres maladies de la peau
DE805416C (de) Zahnpaste
DE102005003708B4 (de) Verwendung von Hautpflegeöl mit Kakaobutter
DE3300491A1 (de) Mittel zur foerderung des haarwuchses und zur verminderung der schuppenbildung
WO2006096998A1 (fr) Agent servant a supprimer des tatouages
DE4134137A1 (de) Haarboden-bioaktivlotion und verfahren zu ihrer herstellung
EP2134315B1 (fr) Composition pour enlever un tatouage
DE19841887B4 (de) Pigmentzusammensetzung für Körperkosmetik und Verfahren zu ihrer Herstellung
DE102005005199A1 (de) Verwendung von Alkylglucosiden zum Erzielen oder Verbessern der mikrobiologischen Stabilität von kosmetischen Zubereitungen
DE4313919A1 (de) Verfahren zur Entfernung von Cholesterinderivaten aus Eigelb
EP0107846A1 (fr) Composition pour les soins ou le traitement de la peau humaine
DE1303074C2 (de) Aromatisierung von lebensmitteln
DE69908259T2 (de) Neues anethanol enthaltend klares gegebenfalls alkoholisches getränk und trübes verdünntes getränk hergestellt durch verdünnung
EP2250994B1 (fr) Gommage corporel
DE3940704A1 (de) Badzusatz und dessen verwendung
EP1281394A2 (fr) Procédés cosmétiques
EP3236920B1 (fr) Préparation antimicrobienne comprenant des alcanes de bispyridinium, des éthers de 1- ou 2-(c1 à c24-alkyl)-glycérol et des alcane-1,2-diols
DE202015005287U1 (de) Zusammensetzung zur Pflege der Haut
DE10329004A1 (de) Kosmetisches Verfahren zur Verminderung sichtbarer Alterungszeichen der Haut
BE1029135B1 (de) Verfahren zur Abtrennung und Reinigung von Wirkstoffen des Seeigels und seine Anwendung
EP2671615A1 (fr) Additif solide de bain avec un profil de dissémination visuel et olfactoric à l'effect retardé
DE4134888C2 (de) Verwendung eines Ölbades als die Wundheilung fördernder Badezusatz
KR20180080058A (ko) 미역귀 추출물을 포함하는 미스트
DE10242138A1 (de) Mittel zur Pflege und Behandlung der Haut
AT221231B (de) Präparate mit mucolytischen und andern wertvollen Eigenschaften

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application
NENP Non-entry into the national phase

Ref country code: DE

NENP Non-entry into the national phase

Ref country code: RU

WWW Wipo information: withdrawn in national office

Country of ref document: RU

32PN Ep: public notification in the ep bulletin as address of the adressee cannot be established

Free format text: NOTING OF LOSS OF RIGTHS EPO FORM 1205A DD 21.11.07

122 Ep: pct application non-entry in european phase

Ref document number: 05714698

Country of ref document: EP

Kind code of ref document: A1